. . . . . . . . . "gleostine is an alkylating drug indicated for the treatment of patients with 1 1 gleostine is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and or radiotherapeutic procedures gleostine is indicated as a component of combination chemotherapy for the treatment of patients with hodgkin s lymphoma whose disease has progressed following initial chemotherapy" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "YIIsVUqMKOMBCDM73KCT4HrfBPWmNfDue/JxxG1241nXy7zQNFxppliHjH7YAAS8E8t2lBTcbGISygHba0WOsXiqVAknsJxBuFlTShq4tK2rlfCPZP4i0jvwLOdYiiV2lvHS2vI/6UOMqxcXJhxPoIoVyheVZ9zHFTYnrs6aN94=" . . "2021-06-13T13:15:47.958+02:00"^^ . . . . .